Skip to search.
 FTSE 100 Down 0.13%

Inovio Pharmaceuticals, Inc. (INO)

-NasdaqGS
7.87 Down 0.05(0.63%) 6 Jul 21:00
Add to Portfolio
Prev Close:7.92
Open:7.80
Bid:N/A
Ask:8.20 x 300
1y Target Est:21.00
Beta:3.33
Earnings Date:10 Aug - 14 Aug (Est.)
Day's Range:7.61 - 8.02
52wk Range:6.33 - 14.20
Volume:1,145,362
Avg Vol (3m):1,386,600
Market Cap:565.14m
P/E (ttm):N/A
EPS (ttm):-0.63
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INODown 0.63%565.14m
AZNDown 0.44%82.31b
PFEDown 0.36%204.74b
SNYDown 2.67%125.91b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):42.87
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.65
Quarterly EPS Est (Jun-15) :-0.13
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback